Malaria Radical Cure Drug Efficacy Clinical Study

SOL #: edc7c95b3da447c7badd45bb67507a4fSpecial NoticeSole Source

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY
FORT DETRICK, MD, 21702, United States

Place of Performance

Syracuse, NY

NAICS

Research and Development in the Physical (541715)

PSC

Health R&D Services; Health Care Services; Basic Research (AN11)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Action Date
Apr 25, 2026, 12:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA) has issued a Notice of Intent (NOI) to Sole Source for a Malaria Radical Cure Drug Efficacy Clinical Study. The agency intends to award a contract to The Research Foundation for The State University of New York (SUNY), citing them as the only responsible source. This study will investigate the safety and efficacy of radical cure therapies against relapsing malaria. Interested parties believing they can provide these services must submit capability statements by April 25, 2026.

Scope of Work

This requirement involves non-personal services to conduct two clinical studies in conjunction with the Walter Reed Army Institute of Research (WRAIR) and the Armed Forces Research Institute of Medical Sciences (AFRIMS):

  • Study 1: Measure the safety and pharmacokinetics of tafenoquine in healthy adults in the U.S.
  • Study 2: Measure the efficacy of tafenoquine in treating malaria in an endemic area in Thailand.

Contract & Timeline

  • Type: Notice of Intent to Sole Source
  • Intended Awardee: The Research Foundation for The State University of New York (SUNY)
  • Requiring Activities: Walter Reed Army Institute of Research (WRAIR), Armed Forces Research Institute of Medical Sciences (AFRIMS)
  • Product Service Code (PSC): AN11 – Health R&D Services; Health Care Services; Basic Research
  • NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences
  • Capability Statement Due: Saturday, April 25, 2026, by 08:00 AM EDT
  • Published Date: March 12, 2026

Submission & Evaluation

This is not a request for competitive proposals. The government believes SUNY is the only technically acceptable vendor. However, interested parties may submit capability statements to determine if a competitive procurement is in the best interest of the Government.

  • Submission Method: Capability statements (PDF, MS Word, or Excel attachments)
  • Submission Email: ashley.n.atkins.civ@health.mil
  • Note: No phone calls will be accepted. If no meaningful written submissions are received by the due date, the solicitation will be issued as a sole source requirement to SUNY.

People

Points of Contact

Ashley AtkinsPRIMARY
Jennifer JacksonSECONDARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Mar 12, 2026
Malaria Radical Cure Drug Efficacy Clinical Study | GovScope